Connect Biopharma Holdings Limited Income Tax Expense Continuing Operations
Connect Biopharma Holdings Limited (CNTB) reported Income Tax Expense Continuing Operations of $60.00 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2024-09-05
CNY
| Period end | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 12 month |
|---|---|---|
| 2023-06-30 | 449.00K CNY 6-K · filed 2023-09-12 | |
| 2022-12-31 | 2.04M CNY 20-F · filed 2023-04-11 | |
| 2022-06-30 | 737.00K CNY 6-K · filed 2023-09-12 | |
| 2021-12-31 | 1.70M CNY 20-F · filed 2023-04-11 |
USD
| Period end | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 6 month as first filed | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|---|---|
| 2024-06-30 | $60.00K 6-K · filed 2024-09-05 | |||
| 2023-12-31 | $120.00K 20-F · filed 2024-04-16 | |||
| 2023-06-30 | $64.00K 6-K · filed 2024-09-05 | $62.00K 6-K · filed 2023-09-12 | ||
| 2022-12-31 | $298.00K 20-F · filed 2024-04-16 | $292.00K 20-F · filed 2023-04-11 | ||
| 2022-06-30 | $110.00K 6-K · filed 2022-09-13 | |||
| 2021-12-31 | $266.00K 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |